FILE PHOTO: View of Pfizer’s new respiratory syncytial virus (RSV) vaccine Abrysvo during its manufacture in this undated handout picture. Pfizer/Handout via REUTERS/File Photo
FILE PHOTO: View of Pfizer’s new respiratory syncytial virus (RSV) vaccine Abrysvo during its manufacture in this undated handout picture. Pfizer/Handout via REUTERS/File Photo